price

NASDAQ · OCUL
Ocular Therapeutix, Inc.
Healthcare · Biotechnology
$11.08
Down-$0.01 (-0.09%)
Updated Aug 22, 2026, 10:04 AM
SID Score
6.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -10.81
- Dividend yield
- 0.00%
- 52-week range
- $7.38 – $11.74
- Volume
- 3.05M
- Avg. volume
- 3.15M
Price performance
OCUL price history
1M range · 21 trading sessions · Daily adjusted prices
OCUL closed at $11.08 after 21 trading sessions, up 30.28% for the selected period.
- Last close
- $11.08
- Period change
- +30.28%
- Period low
- $8.17
- Period high
- $11.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $11.10 | $11.49 | $10.935 | $11.08 | 3.05M |
| Aug 20, 2026 | $11.525 | $11.619 | $11.07 | $11.09 | 3.29M |
| Aug 19, 2026 | $11.29 | $11.74 | $11.185 | $11.73 | 3.02M |
| Aug 18, 2026 | $10.50 | $11.215 | $10.3015 | $11.01 | 4.58M |
| Aug 17, 2026 | $10.80 | $11.195 | $10.50 | $10.65 | 11.15M |
| Aug 14, 2026 | $10.04 | $10.07 | $9.68 | $10.04 | 1.63M |
| Aug 13, 2026 | $10.27 | $10.43 | $10.075 | $10.10 | 2.58M |
| Aug 12, 2026 | $9.77 | $10.43 | $9.74 | $10.23 | 4.01M |
| Aug 11, 2026 | $9.29 | $9.77 | $9.16 | $9.76 | 2.18M |
| Aug 10, 2026 | $9.20 | $9.305 | $9.04 | $9.24 | 1.53M |
| Aug 7, 2026 | $8.80 | $9.20 | $8.80 | $9.19 | 2.02M |
| Aug 6, 2026 | $8.45 | $8.79 | $8.40 | $8.74 | 1.59M |
| Aug 5, 2026 | $8.68 | $8.79 | $8.45 | $8.50 | 1.6M |
| Aug 4, 2026 | $8.40 | $8.715 | $8.355 | $8.59 | 2.23M |
| Aug 3, 2026 | $8.285 | $8.495 | $8.175 | $8.40 | 3.33M |
| Jul 31, 2026 | $8.44 | $8.564 | $8.15 | $8.17 | 2.15M |
| Jul 30, 2026 | $8.37 | $8.53 | $8.27 | $8.47 | 2.69M |
| Jul 29, 2026 | $8.51 | $8.61 | $8.295 | $8.36 | 1.79M |
| Jul 28, 2026 | $8.61 | $8.665 | $8.305 | $8.45 | 2.37M |
| Jul 27, 2026 | $8.64 | $8.86 | $8.475 | $8.64 | 1.54M |
| Jul 24, 2026 | $8.66 | $8.705 | $8.43 | $8.505 | 1.17M |
Latest OCUL news
The latest Smart Investors Daily articles mentioning OCUL.
Stock researchResearch & News · SEC Filings
Loading stock research…

